SPEAKERS

After graduating from the University of Malta as a Doctor and Surgeon Mr. Fearne pursued his studies in various hospitals in the UK including the Great Ormond Street Hospital in London and became a Fellow of the Royal College of Surgeons of Edinburgh. He has worked as a doctor and paediatric surgeon for over 30 years and also lectured students of medicine at the University of Malta. In April 2016 he was appointed Minister for Health after holding the position of Parliamentary Secretary for Health since April 2014. In July 2017, Hon. Fearne was appointed as Deputy Prime Minister.

Jo Etienne Abela was born in Gozo on 29 November, 1975. He lives in Sliema, married and has three children. Attended Sir Arturo Mercieca Primary School in Victoria, Ninu Cremona – Junior Lyceum Complex and sixth form Sir Michelangelo Refalo, all in Gozo. He studied medicine and surgery at the University of Malta between 1993 and 1999 where he later worked as a medical doctor at St Luke’s Hospital. He moved to Scotland in 2003 to further his studies. During his stay in Glasgow he became a Consultant of surgery where he was the youngest surgeon in the whole country. He then specialized on the esophagus and  the pancreas. He returned to Malta in 2012 and a year later began working at Mater Dei Hospital, Gozo Hospital and also as a visiting lecturer at the University of Malta. Professor Jo Etienne Abela has held administrative positions as Deputy Head of the Department of Surgery and Lead Clinician in the High Dependency Unit, endoscopy and pancreatic disease. He also serves as an IST at the Royal College of Surgeons in Edinburgh and is a college and a Union Européenne des Médecins Spécialistes (UEMS) examiner in surgery. He contested the General Election of March 2022 on the 10th and 13th electoral districts and after being elected, was appointed Minister for Active Ageing in the Government led by Prime Minister Robert Abela.

Giovanni Lauricella is the Co-Founder and Managing Partner of Lifeblood Capital, has a Bachelor’s in Finance, a Master’s in Regulatory Affairs in Medical Devices, a Harvard University Certificate for Advanced Negotiation Strategy, and a Università Bocconi Certificate for Private Equity and Venture Capital. Additionally, he has travelled to 43+ countries for his professional focus of talent acquisition and fundraising strategies for MedTech startups. Giovanni has assisted with 2,000+ hires for 500+ clients and facilitated $250+ million in raised capital.

Darshana is Co-Founder and Managing Partner of Catalyst Health Ventures. She is actively involved in all aspects of fund management and has led CHV’s investments in the medical device and diagnostics markets. Darshana currently serves as an advisor of the Deshpande Center for Technological Innovation at MIT, as a Board Director of the New England Venture Capital Association and as a lead advisor to the Portfolia FemTech Fund.

Philippe is a pioneer in the biotechnology and medical devices sectors with experience in both France and Silicon Valley. He is the inventor of 32 patents, including the second highest revenue generating life science patent for Stanford University, earning him entry into the prestigious Stanford University Hall of Fame of Inventors in 2012. He was also awarded Chevalier de la Légion d’Honneur. Entrepreneur, he is the founder or co-founder of MedTech, BioTech and BioEcotech, including Abivax, Vexim, Symetis, Carbios, Affluent Medical, Caranx Medical, Artedrone, SpikImm and Carmat, all of which are Truffle Capital portfolio companies. Education: a former hematology and immunology resident in Paris hospitals, Dr. Pouletty holds an M.D. from t University of Paris VI and Master’s in immunology (ranked first in this elite master) and virology from Pasteur Institute, and hematology from UPMC, was a post-doctoral research fellow (1986-1988) at Stanford University, and the 1999 laureate of the American Liver Foundation. He was chairman for 9 years of France Biotech and vice-chairman for 5 years of Europabio. He conceived the status of Young Innovative Enterprise (JEI) implemented by the French government.

Across her professional career, Addie Harris has worked on foundational, disruptive products in a variety of start-ups, both in medical and non-medical industries. These included Robotic and Imaging systems that were acquired by Stryker, Medtronic, and GE; the iRobot Roomba; the Lego RCX Generation 1 Robot Invention System; and a NASA funded robotics project at Monterey Bay Aquarium’s Research Center - ESP a robotic rapid PCR lab used for deep marine, space, and medical research. Addie created and led the team  at Johnson & Johnson that acquired Orthotaxy, and launched the  VELYS Surgical Robotic System for Total Knee Arthroplasty. In her current role Addie is CEO of Haventure, a medical robotics incubator with more than 15 portfolio companies and successful exits to the industries largest players. Ms Harris holds several engineering degrees from Tufts University and was a Fulbright Fellow in Robotics and Augmented Reality.

VESTECK is a clinical stage endovascular platform technology in the aortic repair, structural heart and surgical markets.  The “Suture-Tight”tm catheter delivers preloaded nitinol sutures to EVAR/TEVAR endovascular grafts securing the grafts to the aorta, either at the time of initial implant or reintervention.  Global opinion leaders tell us that the “Suture-Tight”tm will bring significant benefit to patients, physicians and payors. Mr. Rafferty has leveraged his education with global strategic organizations like ACS/Guidant, CR Bard and J&J Ethicon, to create value, bringing novel technology to the global health care community at startup companies like Pathway Medical, NMS and VESTECK. Mr. Rafferty is a proud graduate of The Temple University, Philadelphia, PA. He and his wife Beth are the proud parents of 4 wonderful children and 4 beautiful grandchildren.

Carolina Aguilar possesses over 15 years of expertise in healthcare, particularly in Medical Devices such as Neuromodulation and Diabetes, as well as experience in consumer goods. She has a passion for cross-pollinating ideas between the scientific and Fast-Moving Consumer Goods (FMCG) worlds. Recognizing the brain as one of the most important organs, Carolina has dedicated a significant portion of her time to its study. This led her to join Medtronic, the world's largest Medtech company, where she led the most advanced neural interface program at that time in Deep Brain Stimulation (DBS). During her tenure in DBS, which spanned a decade, Carolina managed complex businesses in this field, overseeing a Profit and Loss (P&L) of over $140 million. She led large local and global teams, achieving high single to double-digit growth percentages year-over-year. In recent years, she has also been involved in Value-Based Healthcare (VBHC), driving the expansion of the first VBHC provider model in Diabetes for Medtronic. This endeavor included signing a major deal in Saudi Arabia and winning the European VBHC prize in 2017. Carolina's experience with VBHC reinforced her belief in delivering solutions focused on patient outcomes, leading to patient empowerment and the sustainability of healthcare. After an extensive corporate career, Carolina made the decision to contribute to critical innovation at a faster pace. She recently co-founded INBRAIN Neuroelectronics, a company operating in the field of Bioelectronics. Carolina assembled an incredible team with backgrounds in nanoscience, Medtronic, and Philips. Adhering to VBHC principles, INBRAIN Neuroelectronics is developing the next generation of neural interfaces using graphene, the material that earned the Nobel Prize for Geim and Novoselov from Manchester University in 2010. The company is a spin-off from the Graphene Flagship's partner, the Nanoscience & Nanotechnology Institute of Catalonia (ICN2). Leveraging the unique properties of graphene, they aim to decode brain and nerve signals to create breakthrough and sustainable medical solutions.

Kwame Ulmer is a venture partner at Wavemaker Three-Sixty Health. He leads the medtech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation, and advising portfolio company management teams)

Andrew Glass is the CEO of Vivasure Medical, an innovative medical device start-up based in Ireland. Previous to Vivasure, Andrew was a senior executive at Abbott Laboratories for over fifteen years.  He has significant multi-cultural leadership experience in Asia, Europe, and the United States.  Andrew holds a BSE in Chemical Engineering from Princeton University and an MBA from the Harvard Business School.

Wesley Jones, MBA MS, is a Biodesign fellow and medical device engineer specialized in the development of minimally invasive, catheter-based, technology. Mr. Jones has spent a decade leading technical teams from concept to commercialization and has successfully launched 11 devices to market at Medtronic and Acutus Medical.

Michael is a medical device executive, serial entrepreneur, inventor, and part-time venture capitalist. He has a passion for commercializing disruptive technologies that help patients.He has co-founded 5 companies with 4 successful exits to date. Most recently, in 2021, Michael sold Devoro Medical to Boston Scientific.

Sanchita Pasi is a Senior Investment Manager at Sagana with a Pharm.D and an MBA from SDA Bocconi. Sanchita’s experience spans across international MedTech product management and commercialization from her time at Abbott Laboratories. She then transitioned to venture capital starting at Nina Capital and now impact investing at Sagana. She is excited to meet founders who are need-driven and fueled by the goal to improve access and affordability for healthcare worldwide. She has indian roots, a mediterranean upbringing, and is also a painter by night.

Lloyd Diamond, a US citizen, is a seasoned medtech executive and CEO with 25 years of disruptive technology commercialization experience in the life science industry. He most recently served as the CEO of Precise Light Surgical, a commercially ready medical device company in Silicon Valley. Prior to that, he was the CEO of Bonesupport AB, a European orthobiologic company, where he drove rapid market penetration in Europe and the US which led to a successful IPO on the NASDAQ OMX in Stockholm. Lloyd has first-hand experience in the ophthalmology segment as he was responsible for managing Lumenis’ global surgical and vision franchises. He has commercialized many other disruptive technology platforms including at Kyphon and Laserscope. Lloyd received a dual degree in Biochemistry and Marketing from Florida Atlantic University and an MBA from the Thunderbird School of Global Management at Arizona State University.

Kelly Roman has helped pioneer the wearable brain stimulation category since 2009 and has expertise in product development, regulatory affairs, healthcare marketing and clinical trial strategy. Prior to co-founding Fisher Wallace, Kelly graduated from Harvard College and served as an award-winning executive in the digital media and SaaS industries.Headshot attached below

Dr. Yaniv has more than 25 years of experience in the venture capital, pharmaceutical and biotech industries. As a senior manager, skilled physician, and experienced board member, she possesses a highly developed combination of leadership, decision making and business skills. Irit has been a partner at Accelmed since 2012. She is a co-founder of We@healthtech, a HealthTech launchpad program promoting women managers to C-level executive positions throughout the Israeli ecosystem.

Joe Urban is the CEO of Potrero Medical, a commercial stage MedTech company focused on delivering predictive health to hospitals globally. The Accuryn technology utilizes smart sensors and predictive patient monitoring to help critical care patients in Surgery and Intensive Care Units. Potrero Medical has received over $100M in private funding and has been awarded over $7M in Federal grants. The first major health problem the team is solving is predicting and ultimately preventing Acute Kidney Injury, a $25B annual cost to the US healthcare system alone. Joe has over 20 years of healthcare experience in developing commercial teams for a variety of companies, such as Boston Scientific, Auris Health (acquired Johnson & Johnson $6B), and CR Bard (acquired Becton Dickinson $25B). In addition to his corporate experience, Joe formerly served as a U.S. Army Special Operations Officer in Afghanistan for Operation Enduring Freedom, returning home as a decorated war veteran. Joe attended Colorado State University where he received a Bachelors degree in Political Science, and holds an MBA from Georgia Tech. Joe currently resides in Atlanta, GA with his wife and two girls.

Greg is an osteopathic practitioner, exercise physiologist, educator, and Co-Founder of HealthQb, a solution that leverages wearable technology to increase healthspan and longevity. He has a Master's in Exercise Science from Bloomsburg University of Pennsylvania and a Diploma in Osteopathic Manual Practice from the Canadian School of Osteopathy.

Josep has more than 15 years of experience as VC, first co-founding Ysios Capital in 2008 and more recently founding Asabys Partners in 2018 which is managing close to € 300 Mio in health innovation investments. He has specialized in life sciences and healthtech investments in Europe, Israel and the US with more than 10 investments and Boards in the space and some successful exits. Previously he has had a hybrid career in law and finance in the pharma and healthcare world working for Cuatrecasas, KPMG, DomusVi and Almirall. Josep has a Law Degree from Universitat Pompeu Fabra, a Master of Laws from University of Michigan and an MBA from IESE Business School.

Greg Walters (BS Physics/MBA) is a serial entrepreneur and medical device development expert/CEO.  He served in several product development roles for Kensey Nash (acquired by DSM) and was the founder of Essential Medical (acquired by Teleflex).  He holds 50+ patents, co-developed Angio-Seal® and is the inventor of the MANTA® Large Bore Closure device. He is presently the Co-founder and CEO of Excision Medical, a development stage company dedicated to the removal of diseased aortic leaflets to facilitate secondary TAVR procedures.

Julien L. Pham, MD, MPH, is Founder and Managing Partner of Third Culture Capital, an immigrant-founded, physician-led, seed-stage VC firm focused on emerging healthtech and techbio companies that are revolutionizing modern care delivery while optimizing and reshaping the experience of care for both patients and providers.

Co-founder of HighLife, a Cardiovascular Medtech company based in Paris and California, Malek has a biomechanical engineering background. He has developed a Transcatheter Mitral Valve Replacement technology from early concept to production. After conducting pre-clinical testing then First In Human implant, he is now leading Therapy Development and clinical implementation globally.

Edo Ceder, founder of Anicca Health, blends software programming, somatic therapy, artistic movement teaching, and entrepreneurship. With a B.A. in psychology, Edo empowers individuals to reach their potential emotionally, interpersonally, and professionally. Anicca’s product emphasizes emotion management for enhanced physical, emotional, mental, and interpersonal health.

With 10+ years in operational roles in deep-tech projects, Joana Cartocci has a multidisciplinary and multicultural background. Her career spans from linguistics and international relations to coordination roles in deeptech projects that bridge tech, citizen movement, art, well-being and politics. In 2017, she co-founded Robeauté with Bertrand Duplat, to create the next generation smart neurosurgical delivery device to better understand and treat brain pathologies.

Kurt Farrugia was appointed Chief Executive Officer of Malta Enterprise on 1st August 2019. Previously, he served as Head of Government Communication and spokesperson for the Prime Minister between 2013 and 2019. In August 2017, the Prime Minister appointed Mr Farrugia on the Malta-UK Business Promotion Task Force where he actively contributed on matters related to investment promotion in the UK. In April 2019 he was appointed on the New Economic Niches Committee of Malta Enterprise. Mr Farrugia formed part of the Task Force organising the Valletta Summit on Migration and the Commonwealth Head of Governments Meeting held in 2015, as well as the Informal European Council during Malta’s Presidency of the Council of the European Union in February 2017. He accompanied the Prime Minister in most of his international engagements at EU level. Mr Farrugia’s career before his role at the Office of the Prime Minister was in journalism and politics. He graduated in Communications and obtained a Masters Degree in Entrepreneurship at the University of Malta.

David ""DSO"" Suendermann-Oeft, Founder and CEO of Modality, is an AI scientist, engineer, and former university professor. He led industrial and academic R&D labs and has over 200 publications and patents to his name.

Aashiish has 18+ years of experience in Med Device industry in R&D, Marketing, & Strategy roles. Prior to founding xDot Medical in Dec 2020, he served as Director of Upstream Marketing for Medtronic Cardiac Surgery business. He holds an engineering degree from IIT-Bombay and a PhD from Penn State University.

Georgi Chaltikyan, MD, PhD is Professor and Head of Digital Health at European Campus Rottal-Inn (ECRI) of Deggendorf Institute of Technology (DIT-ECRI) in Germany; a Digital Health Consultant for WHO Europe; the Founder and Head of the Center of Digital Head at Russian-Armenian University (RAU-CDH), and the Founding President of Armenian Association of Digital Health (AADH).

Anuj Patel is a seasoned digital health innovator and operator with over 15 years of experience in the healthcare industry. He is the CEO & Founder of Motto, a venture backed digital health platform for autoimmune care and currently serves on the board of the Barcelona based healthcare venture capital firm Nina Capital. Patel holds an MBA in Finance and Health Sector Management from Duke University and a BS in Economics and Finance from Boston University.

Serial medical device entrepreneur with CFO background and prior exits ranging $140M to $800M; prior FARAPULSE co-founder; prior CFO of Surgical Innovation Associates.

An aerospace engineer with 17 years’ experience in the medical device industry, Mr. Smith took part in three successful company exits prior to co-founding Endiatx. He now lives, thinks, and breathes robot pills, zealously guiding a visionary team of engineers to deliver lifesaving telemedicine using micro-robotics in the human body. 

An educator, entrepreneur, and investor, Chris began as an angel investor in Endiatx. However, having never met both of his grandfathers due to colon cancer, he became profoundly moved by the company’s vision and dedicated himself full-time. He now takes great pride in bringing Endiatx’s vision to the world. 

Daniel Hawkins has spent 30 years in medtech in various roles at large and early-stage companies. He is a co-founder of Calibra Medical and founder of Shockwave Medical. Daniel is an inventor on more than 160 patents and applications and has three times been recognized by Goldman Sachs as a Top 100 Most Intriguing Entrepreneur.

Michael Whitman is the founder and CEO of Micro Interventional Devices, Inc. (MID). Michael has over 35 years of medical device experience at market leading firms including, Johnson and Johnson, Olympus, Synthes and Power Medical Interventions. He previously was the founder and CEO of Power Medical Interventions (NASDAQ; PMII), which was acquired by Covidien Ltd. in 2009. Prior to founding PMI, Michael served in numerous management positions at Johnson and Johnson during his 13-year tenure including Vice President of Sales, Director of Sales and Marketing, Product Development and Product Management. He is the named inventor on over 55 US and foreign patents. He received his A.B. in Business and Economics from Lafayette College and completed graduate work at Wharton, University of Michigan, Harvard Executive Education, and Rutgers University.

Mercedes is a seasoned executive in the development of, and investments in, start- and scale-ups in the Life Sciences and MedTech sector. She has a background in Biomedical Sciences focused on technology transfer, and an executive MBA. She is currently Director Life Sciences and MedTech investments for BOM Brabant Ventures.

CATHY SKINNER, CEO is an Executive Healthcare leader with 20+ years of successful experience building businesses, differentiated products, and services that manage healthcare costs and improve patient outcomes.

Matt Jacobs is the Principal and COO of the Cedar Street Group (CSG), an early-stage investment firm focused on healthcare technology companies. Prior to CSG, Matt worked at PPD, a leading global CRO. He has an MBA from Carnegie Mellon University, and a B.A. in Environmental Studies from Lehigh University.

Conavi Medical is an early commercial-stage device company that has developed the first intravascular imaging system that combines ultrasound (IVUS) and optics (OCT). Tom has over 25 years of experience as a leader in the industry and a proven track record of launching and scaling innovative products.

Founder & CEO of Three Bridges M&C, a Medtech Consulting Company providing a wide range of business development services to startups and SME companies. We have a global team of professionals with common values that could bring an extensive set of expertise helping companies in finding suitable solutions and support for their growth Our success is correlated to how successfully we integrate with our clients.

Juliana is a CEO, board member, entrepreneur, and advisor with over 20 years of experience bringing medtech innovation to patients in startup to multi-billion-dollar companies. Over the course of her career Juliana has created companies, facilitated exits doubling shareholder expectations, and developed strategies to grow a billion-dollar business at 15+%.

Victor is a biomedical scientist turned entrepreneur. He leads Aliform, a clinical stage startup specializing in medical devices for skin surgery. With expertise in physiology, medical device design, and combat sports, he guided his team from a simple sketch to a VC-funded company.

Jordan has served as VeinWay’s CEO since its founding in 2020. He brings to VeinWay over 10 years of medical device design and engineering experience.

Stephen Towe is the Chief Executive Officer and Co-Founder of Leo Cancer Care. Stephen has led the expansion of Leo across both the US and Europe. Stephen has built a career innovating and commercialising radiotherapy products and thrives on challenging the norm and improving the quality of care.

Robert J. Greenberg, M.D., Ph.D., is the Chairman and CEO of the Alfred Mann Foundation. He was a co-founder and former CEO and Chairman of the Board of Second Sight Medical Products, Inc. (NASDAQ: EYES) in Los Angeles, California. Dr. Greenberg is a leader in the field of neural prosthetics – having developed and brought to market the world’s most advanced implantable neural stimulator, the Argus II visual prostheses, to treat retinitis pigmentosa, a form of blindness. Dr. Greenberg was also a medical reviewer at the FDA’s Office of Device Evaluation. Dr. Greenberg is the recipient of numerous honors and awards, has over 260 issued US patents and over 100 international patents, and has published over 60 articles. He received MD and PhD degrees from The Johns Hopkins School of Medicine in Baltimore, Maryland. Dr. Greenberg joined AMF in 2004 as Chairman of the Board of Directors.

Mathieu, engineer and INSEAD/WHARTON MBA, is the CEO and co-founder of ASPIVIX, a Swiss MedFemTech revolutionizing women's health. His 20-year journey spanning R&D, Global Marketing, and Sales in MedTech across 8 countries, taught him to challenge the arguments through various lenses and approaches, constantly searching for innovative yet pragmatic solutions.

Humberto Matsuda is the managing partner at Matsuda Invest, an alternative Investments and business development firm based in São Paulo, Brazil. He has over 20 years of experience having managed several funds and direct investments in tech startups in Latin America, North America and Europe, for Family offices and coroporations.

Daniel Powell has over 25 years delivering technical solutions across multiple industries. In 2006, Mr. Powell found his true passion in medical devices, specifically neurostimulation and has since launched multiple product in the space including Deep Brain Stimulation for movement disorders and Vagus Nerve Stimulation for Epilepsy. Mr. Powell co-founded and serves as CEO of Spark Biomedical, the developer of the FDA cleared Sparrow Ascent; a novel, wearable neurostimulation solution to address opioid withdrawal and addiction for adults. Under Mr. Powell's leadership, Spark continues to advance the science of wearable neurostimulation and is developing a solution for Neonatal Opioid Withdrawal Syndrome - addressing the most vulnerable victims of the opioid epidemic, newborn babies.

Dr. Harald C. Ott is founder and CEO of IVIVA, a biotech company focused on developing cures for kidney failure and diabetes. Dr. Ott is a thoracic surgeon at Mass General Hospital, Associate Professor of Surgery at Harvard Medical School and leads the Center for Organ Engineering at Mass General Hospital.

Catello Somma is a LifeScience venture capitalist since January 2020. Prior to this role, Catello is a biotech start-up founder with more than ten years of clinical development and corporate development experience. Prior to this role, Catello worked for a mid-cap biotech where he supported the development of immuno-oncology assets, both internal and in partnership with big pharma, including the preparatory work for a successful licensing opportunity. Catello holds an MSc in molecular biology from the Università degli Studi di Napoli Federico II and an MBA with a major in finance, from MIP Politecnico di Milano.

David Moreau, a mechanical engineer, spent 6+ years in medical devices R&D of large and startup companies, before kicked off a startup project from his PhD work. Now he is backing medtech entrepreneurs at BNP Paribas Développement in the HealthTec venture team.

Alex Condon is a co-founder of Galen Data, a medical device cloud data platform. Previously, Alex was the Chief Strategy officer at Tietronix Software, a NASA contractor focusing on Life Sciences innovations. Alex has represented Healthcare and Space technologies on six Mayor-led international trade missions for the City of Houston.

Joseph Snyder has a Bachelor’s in Sports Management, an MBA in Finance, and a Università Bocconi Certificate for Private Equity and Venture Capital. He has built and led startups with over a decade of sales management experience, traveled to 5 of 7 continents, and supports MedTech startups and public corporations with global talent acquisition and fundraising strategies. Joseph is passionate about designing and building teams in the MedTech and Healthcare Technology industries and is adept at developing strategic industry partnerships with his clients.

Heather Hanson is a proven, successful senior-level executive, known for improving organizational performance and shareholder value through planning, analysis, problemsolving, program development and servant leadership. She leverages her extensive experience in the medical device industry to facilitate growth of the San Antonio biomedical industry as a whole.

Bertrand is at the origin of Robeauté with the vision of developing a therapeutic microrobot for the brain. He designed and built the first microrobot building-blocks to prove the feasibility of his vision early on. Currently he is driving Robeauté’s R&D, as well as the management side of the company

Amir is a MedTech builder, operator, and investor. He is the Founder & Managing Partner of Solardis Health Ventures, a VC group investing in early-stage medical device & digital health innovations. Prior, Amir was the CEO & co-Founder of Spine Align (exited in 2021 to a major orthopedics leader), which developed an imaging platform for real-time, 3D measures of intraop progress during scoliosis spine surgeries.

Currently Clinical & Regulatory Affairs Director at CLIN-r+, Jacqueline brings two decades of healthcare leadership in managing diverse team of clinical, engineering, and regulatory professionals to provide end-to-end solutions to manufacturers. CLIN-r+ specializes in CE submissions and Clinical Development Plans, ensuring technologies reach their clinical and commercial potential by navigating diverse regulatory landscapes, validation testing and expanding to new markets.

Claudia Holy, founder and Managing Director of Podymos, saw firsthand how many marketing agencies missed the mark in the MedTech landscape. Podymos distinguishes itself as a specialist in commercial entry planning, brand crafting, and digital strategy development, all meticulously tailored for medical manufacturers eager to make a genuine impact.

Julie is a C-level industry expert with 25+ years dedicated to corporate growth leadership with experiences ranging from early clinical development through commercialization across pharmaceutical, biotech, and device sectors. Her achievements are based on delivering consistent, above market growth for global and regional initiatives, corporate marketing, and complete life cycle brand management.

An accomplished executive with 30 years of Med Tech experience in the US, Europe and in Asia, Bryce was most recently the President and CEO of New View Surgical, an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS).

Timothy co-founded Owl Peak Technologies and serves as CEO. He started Owl Peak Technologies to create better diagnostic technology for colon cancer patients. Timothy is also an operating partner at QDS Capital, a tech and healthcare focused venture fund. Prior to Owl Peak, Timothy worked in capital markets finance for ten years where he focused on investing, transactions, and early-stage startups.

Dr Robert G. Xuereb MD FRCP(L) FRCP(E) FESC FACC FHFA is the Chairman of the Department of Cardiology, Mater Dei Hospital, Malta and the President of the Maltese Cardiac Society. He was a Nominating Committee Member on the Governing Board of the European Society of Cardiology (ESC) 2020-2022 and is currently a member of the European Association of Percutaneous Coronary Interventions (EAPCI) International Affairs Committee 2022-2024.

Dr. Rahul Kashyap is the CEO and Co-founder of the Global Remote Research Scholars Program. He is also the medical director for research for WellSpan Health in the USA. Dr Kashyap holds a M.B.B.S. degree from TN Dr. MGR Medical University at Madurai Medical College, India and M.B.A. degree from Augsburg University at Minneapolis, USA. He has also completed Global Clinical Scholars Research Training (GCSRT) from Harvard Medical School, Boston, MA. He also has 17+ years of clinical research and quality improvement experience, with more than 225 PubMed cited publications, 20+ book chapters, and has edited two Mayo Clinic books. He brings clinical research methodology, and quality improvement expertise and passion for mentoring and scientific publications, to help advance and highlight excellent clinical care at hospitals.

Founding Director of the Cooper Innovation Center, Dr. Lemon helps rapidly accelerate invention development and startup activity at Cooper University Health in New Jersey. Neal has 15+ years’ experience in technology transfer and innovation management working in Germany, Ireland, Canada and the USA, most recently at the University of Pennsylvania.

AnaMaria Meshkurti, Managing Partner for Europe at Unorthodox Ventures, leads investments in medtech and hardware startups. Previously, she was Head of Marketing, Communications, and Engagement at FONGIT, Switzerland's premier tech startup incubator. AnaMaria, a seasoned mentor and startup judge, focuses on emerging tech like AI, IoT, Blockchain, XR, and the Metaverse. Her UN experience includes ITU roles, where she championed digital inclusion, innovation, and global standardization. AnaMaria's multifaceted career, rich in awards and recognitions, demonstrates her commitment to innovation, gender equality, and youth empowerment on a global scale.

Degrees in radiologic sciences and MBA. Ex-Cleveland Clinic. Former clinical consultant at Siemens, commercialized remote scanning technology, CRO protocol building expert, full-body scanning protocol expert, remote applications innovator, and enterprise sales & strategic partnerships for MRI technology. Currently providing a solution at the intersection of insurance and radiology.

Professor Philip Taylor is Emeritus Professor of Prosthodontics from QMUL where he was a Consultant in Restorative Dentistry and Clinical Director for Barts Health NHS Trust. He has been President of the British Society of Prosthodontics and the British Association of Teachers in Conservative Dentistry. He is the Dean of the Royal College of Surgeons of Edinburgh.

Dr Karan is a general surgeon & online educator with almost 9 million followers across social media. He aims to improve health literacy and public health via digital learning. Additionally he is the author of the upcoming book “This Book May Save Your Life” published by Penguin and is a senior clinical lecturer at Sunderland Medical School.

Anna is a Regulatory Consultant with an extensive knowledge of the medical device field with a PhD in Biomedical Engineering, and over 5 years of experience in helping medical device manufacturers with their regulatory needs. Anna is also the appointed Person Responsible for Regulatory Compliance (PRRC) at Advena Ltd, Authorised Representative in EU for medical device and IVDs Manufacturers located outside the EU who wish to place their devices on the EU market.

Dr Paul Bhogal, consultant Interventional Neuroradiologist at the Royal London Hospital, is the UKs most active Neurointerventional researcher with >180 publications. He is director and founder of BRAIN conference and co-founder of Ceroflo, which is developing state-of-the-art technology to treat intracranial atherosclerosis – the leading cause of stroke worldwide.

Dr. Scicluna, a Senior Lecturer at the University of Malta, previously held positions at the Amsterdam University Medical Centre and the University of Amsterdam. He earned his Ph.D. from the University of Amsterdam and conducted impactful research on sepsis, publishing in prestigious journals like Lancet Respiratory Medicine and Nature Immunology. Dr. Scicluna received multiple research grants, contributed to groundbreaking studies in cancer research, and is a member of international research consortiums. He received the European Society for Intensive Care Medicine's Established Investigator Award in 2022 and has an H-index of 37, making him a world expert in sepsis.

My name is John Xerri de Caro and I am currently working as a Senior Lecturer within the Department of Physiotherapy, Faculty of Health Sciences at the University of Malta. My portfolio ranges from lecturing duties on the undergraduate degree programme, to research coordination (Masters and PhD) and administration. Currently, I am coordinating a post-doc research project as part of a collaboration between the Dept of Physiotherapy and the Ministry for Active Ageing that aims to set the National Policy to Promote Physical Activity through the Retirement Transition.

Professor Michael Griffin OBE became President in 2018, when he was a Consultant Oesophagogastric surgeon at the Royal Victoria Infirmary. He developed the Northern Oesophagogastric Cancer Unit which is now the largest in Europe and North America. A Council member since 2009, he is Chair of the Joint Committee for Intercollegiate Examinations (JCIE) and Professor of Gastrointestinal Surgery at the University of Newcastle upon Tyne. His clinical and research interests have been focused on early diagnosis and radical treatment of oesophagogastric cancers. He was awarded an OBE for services to cancer health care in 2013.

After roles at Imperial College, University College London, and Royal Marsden Hospitals, Dr Khan has been a Consultant Gastroenterologist in Cardiff since 2014, leading the multi-award-winning Neuroendocrine Cancer Service in Wales. With a patient-centered approach, he has clinical and research leadership roles in digital transformation of healthcare including real-world evidence-generation and patient-outcome evaluation through implementation.

Marja Huiskamp is Chief Communication Officer at Barcelona Health Hub, a non-profit organization that aims to promote innovation in digital health. She supports the 450+ BHH member companies to connect with the world of digital health, while building the global BHH brand. In her previous life, she worked many years at the Embassy of the Netherlands in Chile, as well as at different communication roles in the Netherlands.

Max is serial medical device entrepreneur and founder and CEO of Implandata Ophthalmic Products, which is transforming glaucoma care by introducing remote disease management. Prior to Implandata, Max founded two health tech start-ups, establishing disruptive solutions in hydrocephalus management and critical care, successfully exited after regulatory approval and market launch.

Paweł Świeboda is Founder of NeuroCentury, a brain health hub based in Brussels. He is Member of the Steering Committee of the Brain Capital Alliance and Strategic Council of the European Policy Centre. Until August 2023, he had been Director General of the Human Brain Project and CEO of EBRAINS.

Dr Davis is a co-founder and Chief Commercial Office at Hexarad as well as a consultant radiologist; she is also an experienced medical journalist having worked as an Associate Editor of The BMJ for over ten years. Dr Davis has also previously worked at BMJ Open as an Associate Editor focusing on large research trials. In addition to her editorial experience, Dr Davis has participated in multiple National Imaging trials with associated publications.

Dean of the Faculty of Medicine in Sousse, Tunisia, and head of the Obstetrics and Gynecology department. Former President of the National College of Tunisian Gynecologists and actual president of the "National Commission for Specialized Drug Marketing Authorization." Expert for CIDMEF for faculty evaluation and accreditation. WHO expert in perinatal care and maternal mortality reduction [2011-2012]. Member of the research laboratory focusing on maternal health services.

Justus has almost a decade of Digital Health work experience with insurance, pharma and medtech companies internationally and conducted his PhD at the chair of Experimental Bioinformatics at the Technical University Munich about AI implementation in healthcare. Recent publications include 'The Economic impact of Artificial Intelligence in healthcare" in the Journal of Medical Internet Research, Success Factors of Artificial Intelligence Implementation in Frontiers in Digital Health and "Federated machine learning for a facilitated implementation of Artificial Intelligence in healthcare – a proof of concept study for the prediction of coronary artery calcification scores"  in the Journal of Integrative Bioinformatics. 

Abdul is a passionate medical doctor and podcaster operating at the intersection of technology, content creation and education. He is the co-founder of Peerr, a dynamic content platform for knowledge workers to be able to share their knowledge and expertise, acquire micro-credentials, grow an audience and have monetisation control.

Caroline Petit is a high-achieving versatile scientist and jurist by training, and a pharmaceuticalregulatory ad promo leader with 15 years+ of experience. As a strategic multi-awarded businesspartner, she comes with a strong track record of successfully driving global cross-functionalteams collaboratively towards ambitious goals. In her spare time, she belongs to some regulatorysocieties and was nominated Harvard Business School Ambassador.

Dr. Franz Pfister, CEO of deepc, is a medical doctor, data scientist, and entrepreneur. With expertise in AI, technology, healthcare digitization, and clinical research, he strives to innovate Radiology AI for scalable impact in healthcare.

Ariana is an award-winning healthcare innovator and the Co-Founder of Fine Treatment, an R&D and novel medtech company. Her patented Thermobalancing Therapy and therapeutic Dr Allen’s Devices and provide a novel treatment for different health conditions, such as BPH, chronic prostatitis, back pain, and kidney stone disease, improving patients' quality of life and extending healthspan. Educated at the Universities of Oxford, Cambridge, and London School of Economics, she is also a Board Director at OxLEP, and Leadership Fellow at St George's House, Windsor Castle.

Experienced manager and entrepreneur with a wealth of experience in the technology, services, and e-commerce industries. He is the co-founder and CEO of the medical startup KARDI AI, that contributes to preventive heart health monitoring, early arrhythmia detection, and patient treatment optimization through long-term ECG monitoring and artificial intelligence. Within KARDI AI, he focuses primarily on strategic leadership, relationships with potential investors and key partners, and planned international expansion. Stephen Burke was born and raised in northern Vermont, USA.

Simon is a leader in technology-enabled healthcare, having led growth at Virgin Care before leading the market expansion of Kry/Livi in the UK, first as Commercial Director and then Managing Director. More recently Simon has been leading NuvoAir’s efforts, as UK General Manager, to accelorate improvements in cardiopulmonary care.

Susan is a healthcare reimbursement strategist, health policy researcher, and the author of Healthcare’s Reimbursement Maze – The Ecosystem Regulates Market Access to Medical Innovation in the US. She has over two decades of experience in technology, health policy, and healthcare reimbursement consulting. Susan holds master’s degrees in public administration and biomedical engineering.

Dr. Huda Alfardus is a renowned scientist specialized in digital transformation, IP commercialization, and the globalization of technology. With a regulatory sciences and medical research background, she brings her scientific expertise and entrepreneurial acumen to the mission of building sustainable enterprises and developing an internationally integrated business ecosystem. Her policy development and data governance consulting experience enables her collaborations with many government sectors. Dr. Huda served as an Executive Director and co-founder of a UK e-learning/MOOC company that reached over 275,000 clients worldwide, including major tech companies. Additionally, she serves as a general partner for a US-KSA venture capital group, that identifies and supports promising startups. Known for her sociability, approachability, and networking skills, Dr. Huda emphasizes collaborations and advocates for meaningful partnerships in the entrepreneurial ecosystem.

Andrea is an expert consultant in digital transformation and collaborative innovation in Health. Founder of Co-Salud, a boutique digital health consultancy firm and co-founder of the citizen initiative Salus.Coop , a health data cooperative for research. Andrea is also Barcelona Health Hub (BHH) Ambassador and TISAC President and Connector.

Krishna Moorthy is the co-founder of Alviehealth, a digital health start-up providing personalised digital coaching and supportive care for people on cancer and acute care pathways. He is a senior lecturer and consultant surgeon in Imperial College, London, specializing in upper gastrointestinal cancer and complex benign conditions.

Dr Huw Williams is a Senior Clinical Lecturer and Emergency Medicine consultant based in South Wales. After gaining a master’s in medical education he became programme director of the ‘Emergency, Pre-hospital and Immediate Care’ intercalated BSc (EPIC iBSc) degree. Recent projects include a new virtual reality eLearning platform free for all Welsh healthcare institutions; ‘Wales’s Virtual Hospital’ (funded by EU/Welsh Government). He now chairs the All-Wales ‘Immersive Technology Special Interest Group’ (Imm Tech SIG) for the Life Science Hub (Welsh Government).

Dr Halligan is Co-Founder of Prova Health, a next generation provider of clinical trials for med tech innovators. Jack has over 10 years’ experience in clinical medicine, academia, health tech and management consulting. He studied medicine in the Royal College of Surgeons in Ireland and holds an MBA from INSEAD.

Professor Chie Adachi is the Dean for Digital Education within the Faculty of Medicine and Dentistry at Queen Mary University of London. She leads the new Digital Education Studio which consists of a comprehensive multi-disciplinary team of academics and professionals to carry out both strategic and operational work of transforming digital education practices for the Faculty and beyond. Her research interests lie at the intersection of critical digital pedagogy, educational/medical technology and interculturalism in re-thinking how they might enhance teaching and learning practice within the higher education sector. Her MOOC, on FutureLearn, “Transforming Digital Learning: Learning design meets service design” has attracted more than 28,000 global learners worldwide and won multiple international awards, including ‘Best Online Courses of All Time 2020 and 2021 edition’ by Classcentral.

Farzana is a the CEO and co-founder of Hexarad which has created an award winning radiology platform. She was formerly a consultant radiologist at University College Hospital in London. She was also the former Head of Data and Digital Strategy at the Academy of Medical Royal Colleges and an advisor at NHS Digital. As well as her medical degree, she has a Masters degree in Health Economics from the London School of Economics.

With a PhD in neuroscience and years of research experience, Vinoy heads stakeholder engagement at Byteflies, a digital health company building remote patient monitoring solutions. Drawing on his scientific background, Vinoy is driven to develop innovative tools that empower clinicians to deliver improved quality of care to patients in their homes, leading to better long-term outcomes.

Dr Dallas is a dedicated GP specialising in Women's Health and Menopause, with a passion for leveraging technology and service design to enhance well-being. With experience as Babylon's Women's Health Lead and an NHS GP partner, she empowers midlife women to prevent chronic disease. Currently leading the menopause service at a top Harley Street practice, she is committed to transforming women's health.

Thomas helps companies to find and tell better stories for their brands. Together with his team at vm-people, Thomas creates immersive experiences in order to transform attitudes and behaviors. Since the pandemic hit, Thomas has become a frequent traveler of the Metaverse. Equipped with a headset and controllers, he hosts conferences, gives lectures, runs theater courses, throws parties and assists others in exploring the potential of Virtual Reality and the Metaverse for their purposes.

amplifAI health has a strong dedication to transforming healthcare through the digitalization of clinicians' human senses. Our current initiative combines thermal image technology and computer vision to support disease detection.

Dr. Yaron Ilan served as the Vice Dean of the Hebrew University-Hadassah Medical School. Dr. Ilan was a Visiting Professor at Harvard University. Dr. Ilan's main research areas are developing artificial intelligence-based algorithms for care, developing immunomodulatory therapies. Dr. Ilan holds over 50 patents and has authored more than 300 articles. He is the inventor of several drugs and medical devices developed by several pharmaceutical companies. Several of his innovations have already reached the clinical market.

Joel Ugborogho is an accomplished technology leader and entrepreneur, serving as the Founder & CEO of CenHealth, a health technology company specialising in digital health transformation services, health technology solutions, and healthcare professional training through their innovative learning platform, CenHealth Academy.

Peter, a NeuroTech entrepreneur, aims to upgrade human brains. With his team, he's developing a Brain-Computer Interface, improving cognitive abilities, and aiding Alzheimer's patients. After exiting his AI company, he founded Artificial Link and Braingrade. He also mentors at Singularity University and Startupbootcamp and is involved in charitable activities.

UK Government appointed Hassan as its global expert on Digital Health for international trade, 2018-2022. 1 exit, co-founded 2 firms, advising 8. Visiting Lecturer in Digital Health at UCL Global Business School for Health, Editorial Board of The International Journal of Digital Health, and a Vice-Chair of HIMSS UK Community.

Gertrude A. Buttigieg by profession is a licensed Speech Language Pathologist & holds a Masters Degree in Health Management. She is currently reading a 2nd Masters in International Patient Advocacy Management with the Catholic University, Rome. Ms Buttigieg works on a full-time basis at the Office of the Commissioner for the Rights of persons with mental disorders – primarily on Communication and Patient Advocacy. Has also contributed as main author and co-author in various presentation, papers and publications on a local and European Level. On a voluntary basis she serves as the Chariperson of the Malta Health Network (MHN)which is an umbrella organisation which brings together over 40 Health related organisations. Gertrude has participated as speaker and participant in several conferences in Malta and abroad. Since March 2023 she has also been appointed as Chairperson for the Malta Council for the Voluntary Sector.

Matthew is the Group Medical Director for Bupa, an international healthcare company providing both insurance and healthcare provision to more than 38 million customers worldwide. He has experience in implementing innovative clinical products, management of payer-provider relationships, driving novel clinical governance programmes, and leading value-based healthcare initiatives across diverse healthcare landscapes. He is a doctor, specialising in radiology working in the NHS at St Bartholomew’s and Royal London hospitals.

Arron is a GP registrar in London. He is the founder of SimEPR, a novel software used by multiple NHS trusts and Universities to integrate digital skills into medical simulation training. He is also the co-founder of Code Med, an organisation that has taught over 200 clinicians how to code.https://www.linkedin.com/in/arron-thind/

Imran Qureshi works part time as a Consultant in Infection for Croydon University Hospital and part time for Amazon as their Principal Medical Consultant. He is an Associate Professor at UCL for Quality Improvement and Innovation and co-founded Code Med, an organisation which teaches coding to healthcare students and professionals.

Richard Houlihan(EirMed Ltd) is an international speaker on EUDAMED. After running the EUDAMED IT teams he has unrivalled insights into EUDAMED. EirMed ( Eudamed.com) provide consultancy, support, training, and data submission software for EUDAMED and GUDID. EirMed has trained over a thousand people, helping hundreds of companies with EUDAMED consultancy and data submissions.

George is a former military doctor turned Entrepeneur. He started Oto after suffering from tinnitus himself and experiencing first hand the difficulty in managing his patients’ tinnitus. He now leads the development of the digital platform and product development at Oto.

Dr. Quy Vo-Reinhard, a serial entrepreneur and experienced director, champions equitable innovation and data control access. Co-founder / Director of dHealth, a leading blockchain infrastructure for healthcare, she inspires through dynamic leadership. Honored as 'Most Influential Woman in Blockchain in Europe' (Blockshow 2018) and a Female Digital Innovator in Switzerland.

Sarah supports innovative medical device, diagnostic, pharmaceutical, biotech, and technology companies on EU and UK regulatory, compliance and transactional matters. She has particular expertise in helping medical device, diagnostic and digital health companies navigate regulatory frameworks while balancing challenges presented by the pace of technological change over legislative developments.

To bring emerging and breakthrough technologies to patients, we need to address the challenges healthcare faces today. Satu Peltonen is a firm believer in equal healthcare and that modern innovations offer the way to achieve this. She is the founder of inXso, a company focused on healthcare innovation and emerging technologies. Experienced in complex medical systems, she offers insights into the integration of innovative, personalized, and precision solutions in healthcare internationally. She has been internationally active for 25 years in Germany, the US, Switzerland, Japan, and China, focusing on medical technology and research for the past decade.

Digital exec, serial entrepreneur, PE investor: Ranjan has been innovating and investing in sectors on the cusp of transformation throughout his career. Ranjan co-founded HealthHero in 2019, quickly growing it to become the European leader in digital telehealth. HealthHero is a digital first, end-to-end healthcare provider, which combines gold-standard clinical expertise with breakthrough tech to enhance people’s whole health and optimise healthcare efficiency.

George Yeboah Kesse is an experienced healthcare technology manager and leader with expertise in pharmaceutical supply chain, business development, and strategic planning. He holds degrees in health services administration and an executive MBA in leadership. George has successfully driven innovation and growth in healthcare through his own startup, Advance Pharma Innovations, and has consulted for various organizations and government bodies in Ghana. He is dedicated to leveraging digital solutions to improve healthcare delivery and patient care.

Sinead promotes the digitisation of healthcare, working with startups, research and education. With a background in management consulting and data analytics, she has worked internationally across the spectrum of healthcare including hospitals, Pharmaceuticals and Medtech. Her expertise ranges from harnessing the value of data, especially artificial intelligence, to developing business models and strategy for digitally enabled innovations. She is the Ireland-UK Steerco member for the European Health Data Space.

Ian Slade is a Healthcare Executive Consultant & Transformation Specialist. He is passionate about helping clients drastically improve patient care through Emerging Technologies. He has extensive consulting experience in Asia, North America, and Europe. He has completed Economics and AI graduate programs from MIT and Stanford. He also has Master’s Degrees in Psychology and Business, and a Bachelor’s Degree in Nursing. Ian co-founded HPMA, Healthcare Project Management Association. This digital platform is dedicated to improving Healthcare globally through better execution of projects. Currently, there are 3,000+ members from more than 50 countries. He has multiple national and international awards that includes HIMSS Global Advocate of the year 2022, IFAH Visionary 2021 and Healthcare Tech AI Award 2021 to name a few. He was a keynote speaker at the Global Health 2.0 Conference in Dubai in 2022 on the topic of the Metaverse and Mental Health. Since 2018, he has served as an instructor for UCLA Physician Informatics Fellowship Program and the Project Management Training Course. He serves as a senior strategic consultant for multiple Executive Leadership Teams in various organizations in California. Currently he also serves as lead for the Digital Health Collaborative for Women in Technology International. He currently resides in Irvine California with his family and his Shih tzu poodle, Charlie.

Dr. Ali Tinazli (CEO, lifespin) has 15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP). a deep background in the science and business of biomedicine and healthcare as well as technology convergence between digital/consumer technologies and healthcare. Pioneering accessible and scalable Precision Medicine tools globally is Ali’s mission.

Dr Jing Ouyang is an NHS doctor and COO and Co-Founder of Patchwork Health. Patchwork’s tech-enabled end-to-end workforce management solution is helping to optimise outcomes for organisations, managers, staff and patients alike, by making healthcare staffing more sustainable. Previously, Jing was a Clinical Entrepreneur Fellow and has worked on a number of digital health innovations within NHS organisations.

Dr Anas Nader is an NHS doctor and CEO and Co-Founder of Patchwork Health. Patchwork’s tech-enabled end-to-end workforce management solution is helping to optimise outcomes for organisations, managers, staff and patients alike, by making healthcare staffing more sustainable. Previously, Anas was also a Darzi Fellow and a Clinical Innovation fellow at Chelsea and Westminster Hospital NHS FT.Dr Anas Nader is an NHS doctor and CEO and Co-Founder of Patchwork Health. Patchwork’s tech-enabled end-to-end workforce management solution is helping to optimise outcomes for organisations, managers, staff and patients alike, by making healthcare staffing more sustainable. Previously, Anas was also a Darzi Fellow and a Clinical Innovation fellow at Chelsea and Westminster Hospital NHS FT.

Remko Schats, PhD, MBA is a medical doctor with a strong commitment to Global Health. Through his international missions, he has demonstrated versatility and a drive to make a difference. He is currently launching Σnigma, an innovative Global e-Health platform. Additionally, he delivers impactful leadership lectures and workshops, inspiring others to excel in their own endeavours. Learn more on my website: www.remkoschats.com/about

Mr. Rajnish Mankotia M.S, FRCS(Ed), PGCertME is a healthcare leader and a general and laparoscopic consultant surgeon (colorectal) with 18 years of NHS experience and over 9 years of consultant experience. He is passionate about the role of AI in healthcare and medical education, and the use of digital healthcare technologies to foster collaborative communities that support and mentor colleagues worldwide. He is a Co-Founder of www.thegutclinicuk.com, a physician-led platform that empowers patients by providing access to valuable medical information, enabling them to make informed decisions and choose the best Gut specialists in the UK. The platform's core mission revolves around identifying and uniting Gastroenterologists, Bariatric Surgeons, Upper GI Surgeons, and Colorectal surgeons from all corners of the country. Led by physicians, the platform aims to connect patients with top specialists across the UK, empowering them with medical information to make informed decisions about their healthcare.

Keith is a Digital Health & Innovation Consultant with over 2 decades of experience of frontline clinical practice as an NHS GP. A veteran of successful UK and International digital health projects and product launches, he specialises in getting doctors excited about new ideas.

Dr. Bela Venesz, PhD, gained his business experience primarily in the field of medical device product development and innovation. Throughout his professional career, he recognized the challenge of identifying suitable lead users to collaborate on co-created new product development with developer-manufacturer firms. As a result, he embarked on a research project during his PhD studies to investigate the personal profile of potential collaborators, particularly medical doctors. His findings revealed that innovators must actively participate in the whole development process and possess six specific personal attributes to achieve technical and market success of the innovation.

Rajesh is a Consultant in Renal Transplant & Dialysis Access Surgeon, Lead for Robotic renal failure Surgery, Access for Dialysis, Research and Innovation at Bartshealth NHS Trust, London, United Kingdom. He is the Lead for Robotic Renal Failure Surgery, Chair of Multispeciality Robotic Research Group and Lead for Surgical Education Year 5 at Queen Mary University of London. He strives to introduce advances in renal failure surgery to our patients and offer robot assisted renal transpaltnation, performed with colleagues the endovascular arteriovenous fistula (scarless AVF), 1st time in UK and developed the world’s first scoring system to predict outcomes following intestinal transplantation. Rajesh is passionate about empowering patients living with kidney disease by demystifying many aspects of their care including dialysis access procedures and renal trasplantation and support their families by improving knowledge about donation from live and deceased donors. He is an experienced consultant and Entrepreneur with knowledge in healthcare management, clinical research, and healthcare information technology. He leads many clinical and technology-based innovations to empowering patients living with chronic diseases such as kidney failure, demystifying their care. He leads research projects to validate digital innovation-based solutions and facilitate integration of many technologies into healthcare. He is a member of advisory boards and as a key opinion leader, guides development of healthcare innovations across the globe.

Dr. Neel Patel is the CEO & Co-founder of ZiO Health, a Medtech company that has developed an AI-driven point-of-care device for therapeutic drug monitoring & precision dosing. After practicing medicine, he obtained an MBA from the University of Oxford and currently holds positions as a venture partner & startup advisor.

Dr Elnazer has dedicated her work to optimize chronic care management, she has innovated a clinical digital system " The 7 Step System" to treat chronic complex patients through individualized health plans, consistent follow ups, tracking and patient education. It was the first health system to digitize healthcare management & delivery in Egypt years before the normalization of telemedicine during the Pandemic.

Medical Doctor, High Performance Coach, Entrepreneur, TEDx speaker and Founder of Empowered Global, Dr Alisha effortlessly bridges the gap between health and high performance in a world of exponential digital growth. Her programmes are designed to elevate global impact through the art and science of human optimisation and leadership.

I am a medical doctor specialized in pediatrics, with over 7 years of experience. I work in Health Informatics, where my focus is on exploring how technology and software tools can create a more efficient, agile, and pleasant experience for users. My ultimate goal is to improve the quality of life by revolutionizing healthcare with technology.

Konrad is National Director of the NHS Innovation Accelerator (NIA) which supports exceptional individuals to scale best in class business across NHSE for patient, system and staff benefit. He is also the Chief Enterprise Officer for UCL Partners, an NHSE ASHN, driving the innovation pipeline, adoption readiness of mainly digital health solutions, industry and trade bodies engagement and working with universities. He is working with key NHS leaders in both roles. Prior, Konrad worked for Novartis and Pfizer, driving large scale digital transformation projects across global markets.

Ravi Ramaswamy, post his retirement from Philips (Sr. Director & Head-Health Systems at the Philips Innovation Campus at Bangalore) in Sept 2020, is now CEO, RV Consultants.  He advises Global and Local Healthcare Corporations on Strategy, Growth and diversification as also Product & Program Management. He is on the Board of several Incubators, Start-ups and Educational Institutions. He also Coaches and Mentors Senior Leaders in the ecosystem.

Elina has committed her decade of experience in social entrepreneurship to empowering people and companies to be more productive and fulfilled. Essence targets the intersection of women’s health and tech by using the menstrual cycle to boost productivity. Elina's mission: to build a world where periods are a superpower.

Dr. Mariana Zamir is board-certified dermatologist and experienced Mohs surgeon passionate about MedTech innovation. Dr. Zamir is committed to leveraging healthcare outcomes by improving accessibility to medical services and integrating digital health in everyday patient care. Ambassador of healthcare equity through various volunteering platforms, Dr. Zamir advocates for patient rights and wellbeing.

Oshin Behl is a Harvard-certified leader in medicine with a physician-scientist background. Apart from being a venture manager at the Creative Destruction Lab (an early stage startup mentorship program), Oshin also serves as partner at a boutique digital health and medtech-startup consulting firm, FuturaHeal and as president at a global non-profit, Global Consortium of Medical Education and Research (GCMER).

Finn is having a passion for realising Strategy and Benefits through Project, Portfolio, Change and Transformation management. His focus is to maximise the performance of the organisation he works in, focusing on the people that makes and take advantages of projects implemented but also value and benefits are made sustainable.

Mysty is a second-career healthcare advocate that brings over twenty years of prior health care industry experience into the practice of law. Mysty advises clients on health care regulatory, reimbursement, and litigation matters.  She helps health care companies achieve their strategic goals through her legal representation.

Przemek is an experienced executive advisor with over 100 completed strategy and commercial development projects for leading medical devices companies. His work spans areas such as asset and portfolio strategy, new market entry, commercial due diligence and licensing, as well as regulatory approval, and market access strategy in the US and European markets.

Adel is Medical Director for Ada’s enterprise partnerships and is an experienced practicing NHS physician. He is also the co-founder of 'Doctors in Tech', an organisation established to create a network to support clinicians working in this newly emerging 'specialty'. Adel is passionate about empowering patients and enhancing the clinician experience through technology.

Dr Ayesha Rahim is a psychiatrist, with 20 years’ experience in the UK National Health Service. She has worked in health tech for a number of years, and is the national clinical lead for Digital Mental Health in England. Her other interests include workforce development, diversity & inclusion, and user-centred design.

A digital health futurist, An innovation enthusiast and a strategy advisor to healthcare authorities and ministries in the middle east with an experience of 23 years in healthcare economy. Areas of experience are: Digital Health Innovation, Health Informatics workflow optimization, eHealth Regulatory Framework and Compliance, Health Information Systems/Health Information Exchange, Digital Maturity and Accreditation

Kaisa Kauppinen is a seasoned design professional having worked within design over 20 years. For the last four years she has focused on social welfare and healthcare IT solutions at Tietoevry. Kaisa is also doing a PhD on human-centered design and benefit realization management at the University of Oulu in Finland.

Dr Sarah Bateup is Chief Clinical Officer at Oliva. Sarah is a CBT Therapist. She founded the first primary care CBT service in the UK, before becoming the CCO at ieso where she was instrumental in learning how to use technology to amplify the effect of psychological therapy, resulting in several awards and publications.

He leads Sanara Ventures, an Israeli based healthcare innovation fund, backed by Phillips and Teva, since its inception in 2015. Mr. Barnea is also the Managing Partner of Sanara capital, a follow-on fund to Sanara ventures that invests in Digital Health, Medical Devices & Bio-Convergence companies, and a recognized keynote speaker, sharing his views and vision in various healthcare and digital health conferences across the globe. In addition to leading Sanara, Mr. Barnea chairs the Life Science Advisory Board at The Israel Export Institute, on behalf of the Israeli government, promoting and advancing the export of Israeli technologies in the medical, biotech, pharma and digital fields in global markets. A valued consultant, Mr. Barnea was an advisor to the World Bank’s IFC venture capital team and a co-founder of the IFC’s Tech Emerge initiative; a unique acceleration platform that connects healthcare startups from around the world with leading corporations and hospitals in emerging economies. On December 2018, Tech Emerge Health has won the world bank group president’s award for innovation.Formerly, Mr. Barnea was one of the founders of CardioSense, a MedTech startup company that developed a probe for early shock detection in various medical settings.

Mr. Aloys RUKUNDO is the Founder & CEO at Hellomed, a telemedicine Startup based in Kigali, Rwanda providing easy and affordable accessible healthcare using modern technology. Prior to Hellomed, Aloys Co-founded Watotosmile ltd a social enterprise that focused on literacy boost for children and teenage girls from low-income communities

Associate Professor Sandeep Reddy is an Artificial Intelligence (AI) in healthcare researcher based at the Deakin School of Medicine besides being the founder/chairman of Medi-AI, a globally focused AI company. He also functions as a certified health informatician and is a World Health Organisation recognised digital health expert. He has a medical and healthcare management background and has completed machine learning/ health informatics training from various sources. He is currently engaged in research about the safety, quality and explainability of the application of AI in healthcare delivery in addition to developing AI models to treat and manage chronic diseases. Also, he has authored several articles and books about the use of AI in Medicine. Further, he has set up local and international forums to promote the use of AI in Healthcare in addition to sitting on various international committees focusing on AI in Healthcare.

Kelsey Crossman is a business development manager at German startup Simq, which specializes in the adoption of computer simulations and digital twins in healthcare. She has a deep understanding of the healthcare industry and how technology can be used to improve patient outcomes.

Susan is a visionary marketing executive with a proven career in global brand and marketing strategy for market leaders such as Edwards Lifesciences, Thomson Reuters, and LexisNexis. She uniquely established herself as a pioneer and leader in harnessing the power of digital innovation in the medical device industry to positively impact patient care and engage clinicians.

Oliver is a strategy adviser and applied ethicist. He was Strategy Director and Head of Ethics at Koa Health from 2016 to 2022. He was also a Senior Civil Servant in the UK Department of Health and a Policy Adviser in the Prime Minister’s Strategy Unit under Tony Blair.

Ralf-Gordon Jahns is the Managing Director of Research2Guidance, a leading market analyst and strategy consultancy company for the global digital health market. Since 2008 Ralf has strategically advised healthcare companies and start-ups to better understand the value of adopting digital innovations, navigate through new market opportunities, and build successful partnerships.

With knowledge about how to get regulatory approval, I decided to take matters into my own hands and create a digital platform, with a work-break-down-structure that would allow MedTech companies to accelerate a compliance framework into organisations to become and remain compliant, at a fraction of the cost and hassle.

Senior NHS manager with extensive experience managing analytical and business intelligence teams to ensure delivery of timely, accurate reporting, analysis, intelligence, insight and predictive analytics in service improvement, service redesign, transformation and integration. Working on digital and data strategy to support intelligence with a strong emphasis on Population Health Management.

Novalins is a triply-ISO-certified medical translation provider working exclusively in the healthcare sector. We have over ten years' experience providing certified medical translation services to 220 healthcare companies, including 130+ global MedTech companies with the most challenging needs in over 120 languages across Europe, America and Asia, making use of cutting-edge technology such as specialised TMS and our own proprietary technologies: our Clients' Portal and Project Management Platform.

Alex has extensive experience in business and engineering, specifically in the healthcare industry. He is passionate about the convergence of modern IT technologies and medicine. In 2020, Alex founded Medentee, a web-based platform and mobile application that facilitates secure, efficient, and convenient communication between healthcare organizations, medical professionals, and patients

Pilar is a Go-to-Market expert with 20+ years of experience in international sales, partnerships, and business development in the Health and Tech sectors. Currently, Pilar is the founder of i-Expand, an advisory firm a boutique advisory firm focused on assisting Health Tech companies grow and scale faster, with less cost and less risk. A passionate believer in innovation through technology, Pilar has assisted both high-profile organisations and start-ups across 6 continents. In the private sector, she has been part of the global leadership teams of Cisco and Wolters Kluwer. She has also led delegations to the UN/WHO, standardised digital health solutions at national level, and helped raise 350M in funds. Pilar is fluent in 9 languages, holds 2 First-class degrees and is PMO-certified by Stanford. In 2023, Pilar will publish her book: “Cash or Crash- How to launch your digital health business. Successfully”.

Michael is a global entrepreneur and investor. For the last decade, he’s been building a health tech company to connect clinical teams to their hospital patients. He’s now supporting other founders as an investor and coach, leveraging his learnings to accelerate the journey of others.

I obtained my MD and MSc from the universities of Malta and Edinburgh respectively. Having completed my surgical training at the Mater Dei Hospital, I am currently sub specialising in reconstructions following breast cancer surgery. I have a research interest in computational surgical guidance as well as digital health applications.

Roseanne Camilleri is the Chief Executive Officer, Primary HealthCare (2017, to-date). This position followed her 10-year tenure as CEO-Pharmacy of Your Choice (POYC). She is an MBA Graduate (Distinction) from Grenoble (France), a Birmingham University Certified Postgraduate in Hospital Management, a Fellow – Institute of Leadership and Management (UK), a Fellow of the Royal Society for Health Care (FRSPH) and Associate Dean Queen Mary University of London -Malta, and an Honorary Clinical Senior Lecturer in the Centre for Medical Education within Institute of Health Sciences Education (Barts School of Medicine). Ms Camilleri served as the statutory Chairperson of St Luke’s Hospital Management Committee. She authored myriad strategic reports and drafted the 2004 National Pandemic Influenza Preparedness Plan. Ms Camilleri received the Malta Best Health Care Entrepreneur of the Year 2016 Award. She was conferred with the 2017 Gieħ San Giljan and in December 2020 – the Covid 19 Year – Roseanne secured three distinctive accomplishments – the Health Entrepreneur for the Year 2020, the Malta Business Review Chairman’s Value Award and the exceptional Lifetime Achievement Award for Health Care. In December 2021, she was bestowed by the President of Malta with the esteemed National Worker of the Year 2021 Award, and in October 2022, Roseanne received the ‘Outstanding Role model Leadership of the Year’ Award at the Malta’s Best Businesswoman of the Year Awards.

Mr Kenneth Brincat has been appointed MDIA’s CEO in 2021. Enhancing the successes achieved during the initial years of the MDIA, Mr Brincat is spearheading the strategic direction of digital innovation in Malta. He holds a Master of Science Degree in HR and Training and currently reading for a Doctorate in Business Administration.

Fruzsina is a thought leader in digital health innovation, health policy and health financing on a European scale. As a health economist and digital health consultant her focus is health technology assessment (HTA) of digital health innovations and pioneering medical technologies. She is currently coordinating the European Taskforce for Harmonised Evaluation of Digital Medical Devices (DMDs) – a pan-European effort to facilitate the accessibility of DMDs through harmonising the major elements of a digital health specific HTA framework across EU Member States. She has been recently elected a presidential board member of the Hungarian Health Economics Society to implement good practices of international digital health regulations into Hungarian setting.

Georgina has been leading Web3.0 projects in the healthcare space since 2018 being published in the Lancet and other leading journals for her research in the topic as part of her MSc in Blockchain. Prior to this, she qualified with PwC London where she specialised on auditing major healthcare organisations such as Novartis and IMS Health.

Manish Chand is a practising robotic surgeon at University College Hospital, London as well as a Clinical Academic and Professor of Surgery at University College London with an interest in AI and Advancing Imaging. He is also Chief Medical Officer for The AIS Channel and Chief Design Officer for OstomySecure.

Georgi Kadrev is an innovator in the area of visual AI, pioneering concepts such image recognition API and coining terms like image auto-tagging back in 2008. Most recently Georgi co-founded Kelvin Health with the mission to make diagnostics accessible for everyone, in every context. The company has received multiple global innovation awards since its inception in 2020.

Andy Bleaden works for ECHAlliance as the Communities Director where he has developed and built a large network of over 70+ Global Digital Health Ecosystems, 12 thematic innovation ecosystems and grown a Membership Community of over 900 Health organisations.He has had a long career in both health and social care as well as funding going back over 30 years starting in the mental health field working with mentally disordered offenders, homeless young people, regeneration and economic development and then later in the field of social care, dementia and robotics. Alongside this Andy has been an External Expert for the European Commission since 2013 assessing proposals and  reviewing projects. He has worked for the European Institute of Innovation & Technology (EIT) on  both Health and Manufacturing programmes. He has assessed proposals and reviewed projects for other funds such as  Urban Innovation Actions, Urbact and Innovative Medicines Initiative

Anamaria is specialised in innovation, entrepreneurship and business development, including by access to various types of EU, public and private finance. She has been working both on the innovators’ side, and on the side of numerous EU, governmental and intergovernmental funding agencies and programmes (e.g. Horizon, EIT, AAL, BlueInvest, in Malta, Cyprus, Ireland, UK, Czechia, Slovakia, Georgia, etc.)

Philippe is a TEDx and inspirational speaker, a digitalisation humanist and a futurist. Philippe is regularly speaking at major international events all over the World and mainly in the Healthcare space. He recently received an “Outstanding Leadership in Healthcare Award” in March 2022 in Dubai.

Dr. Mendoza is a highly experienced medical doctor specializing in gastroenterology, with an impressive 20-year career spanning across Spain, Portugal, and The Netherlands. In 2017-2018, they obtained a Master's degree in Digital Health from LaSalle University in Barcelona, further enhancing their expertise in the field. In 2020, they completed a Digital Transformation course at the Massachusetts Institute of Technology. Throughout their career, they have held significant roles, such as serving as a medical advisor at Medify in 2019 and a medical consultant at Savana, an NLP company in healthcare, in 2020. Since 2019, they have been a co-director in the Healthcare area at OdiseIA, a non-profit association focusing on ethics and artificial intelligence. Dr. Mendoza has also participated in the Reach KOL Faculty Program at Reach - Thought Leadership, a non-profit organization, since 2020. Additionally, they currently serve on the advisory board and hold the position of leading metaverse doctor at Aimedis, an innovative platform (www.aimedis.io), starting from 2022. As of January 2023, Dr. Mendoza holds the esteemed position of Director of the Healthcare area in the Metaworld congress in Madrid, the first congress in Spain dedicated to the exploration of the Metaverse, Blockchain, and Web3 technologies.

With a Master of Science in Healthcare Management and 6+ years of experience in various roles in the health-tech industry, Lisa leads the international digital health startup ecosystem at 5-HT where she provides coaching and enables valuable matchmaking & collaboration projects between relevant corporates and startups.

Mr. Kenneth Shaw is a regulatory and quality consultant, as well as the founder and director of Specculo, a consultancy firm providing high-quality and professional consulting services to manufacturers and other economic operators around the world. Specialising in medical devices, Kenneth has experience in helping countless manufacturers obtain their CE mark and enter the EU market. 

Ana, a COO with an Executive MBA from IE Business School and digital transformation executive training, brings 15+ years of medical technology experience to the table, specifically in fertility, women's health, and related applications. She directed operations at Overture, automating assisted reproduction labs that secured Google Ventures' first investment in Spain. Recently, Ana co founded Prefree, an AI-based Preeclampsia diagnostic solution that centers on patients and aids physician decision-making.

Maryn is the General Partner and the Head of Europe for the Global Health Impact Fund. He is also the author of the HealthVC newsletter on Substack where he covers the terminology of venture capital as well as current trends and investments in the health tech space.

CEO of Softcare Studios, a digital health startup developing VR solutions for drug-free pain management. Ph.D. in Neuropharmacology, he is also an advisor on digital safety and privacy in the Metaverse (focus on child safety and medical XR) as a member of the Extended Reality Safety Initiative (XRSI).

Jhonatan Bringas Dimitriades, MD is a Medical Doctor and executive who works with technologists, developers, medical professionals and patients to deliver digital and technical solutions to enhance the diagnosis, treatment, recovery and quality of life of patients around the globe. 

Jhonatan believes in the democratization and digitalization of medicine. Dr. Bringas has worked in the implementation of medical technologies in some of the top medical centers worldwide. His work related to medical implementation of technologies, digital health, and innovation has been featured in written and spoken media. Jhonatan is one of the co-Founders of Lapsi Health, Digital Health startup that is developing Digital Biomarkers for multiple usages in Medicine. 

Jhonatan is a certified Occupational Physician, with postgraduate education in Public Health, Business Strategy and Digital Health. Jhonatan holds a Medical Degree, re-certified in 3 continents and has held the positions of Medical Director, Chief Medical Officer and Chief Medical Communications Officer at a number of companies. He currently has appointments as faculty in Digital Health at several universities. 

Lilian M. Azzopardi, a Professor of Pharmacy and Department Head at the University of Malta, is a trailblazer in pharmacy education. She spearheaded the international doctorate in pharmacy in collaboration with the University of Illinois at Chicago. Azzopardi excels at integrating fundamental sciences and practice, offering experiential and interprofessional learning. She received research accolades from the International Pharmaceutical Federation (FIP) and the European Society of Clinical Pharmacy. Azzopardi played vital roles in FIP initiatives and currently serves as President of the European Association of Faculties of Pharmacy.

A nephrologist and intensive care specialist by training, Tim is an experienced health technology entrepreneur. Tim was CEO of Doctors.net.uk and M3 (EU) before co-founding Cognitant Group in 2018. He is president of the Digital health council at the Royal Society of Medicine, and a non-executive director and adviser for several other health technology companies.

Daniel is a Health & Pharma Lawyer. As a Partner of PRA-Raposo, Sá Miranda & Associados, he is the Head of the Health, Pharmacy & Biotech Economic Unit. Based in Portugal, he was also a member of the National Board of Bioethics, to which he was elected by the national parliament. Daniel is the President of the Portuguese Association of Health and Law. Having a degree in Law and an L.LM in Innovation, Technology and the Law by the University of Edinburgh, Daniel has focused his research and professional career in IT and Health and Pharma Law.